Aicardi-Goutieres syndrome is an inherited encephalopathy that affects newborn infants and usually results in severe mental and physical handicap. There are two forms of the syndrome: an early-onset form that is severe, and a late-onset form that has less impact upon neurological function.

 

DelveInsight’s ” Aicardi Goutieres Syndrome Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Aicardi Goutieres Syndrome , historical and forecasted epidemiology as well as the Aicardi Goutieres Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

 

Some facts of Aicardi Goutieres Syndrome Market are:

• Around 80% of patients presenting with the severe form die within the first 10 years of life but prolonged survival after the first decade of life has been reported in milder forms.
• Aicardi-Goutières Syndrome is listed as a rare disease by the Office of Rare Diseases of the National Institutes of Health (NIH). Aicardi-Goutières Syndrome affects less than 200,000 people in the US population.
• As of 2014, roughly 400 cases of AGS were known, and just over 120 cases had been reported in medical literature so far.
• About 40 percent of people with AGS have painful, itchy skin lesions called chilblains. Chilblains usually develop on the fingers, toes, and ears.
• When both parents are carriers of a specific mutated gene, such as those for AGS, their children have a 25% chance of being affected by the disease, a 25% chance of neither being a carrier nor affected, and a 50% chance of being an unaffected carrier, just like their parents.

 

Request for Free Sample Page: https://www.delveinsight.com/sample-request/aicardi-goutieres-syndrome-market

 

Scope of Aicardi Goutieres Syndrome Market Report are:

• The report covers the descriptive overview of Aicardi Goutieres Syndrome , explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
• Comprehensive insight has been provided into the Aicardi Goutieres Syndrome epidemiology and treatment in the 7MM
• Additionally, an all-inclusive account of both the current and emerging therapies for Aicardi Goutieres Syndrome are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
• A detailed review of Aicardi Goutieres Syndrome market; historical and forecasted is included in the report, covering drug outreach in the 7MM
• The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Aicardi Goutieres Syndrome market

 

Some of Aicardi Goutieres Syndrome Companies are:

• Eli Lilly
• And Many Others

 

Request for Free Sample Page: https://www.delveinsight.com/sample-request/aicardi-goutieres-syndrome-market

 

Aicardi Goutieres Syndrome Therapies are:

• Baricitinib
• Lamivudine
• Abacavir
• And Many Others

 

Table of Contents:

1. Key Insights

2. Executive Summary of Aicardi Goutieres Syndrome

3. Competitive Intelligence Analysis for Aicardi Goutieres Syndrome

4. Aicardi Goutieres Syndrome : Market Overview at a Glance

4.1. Aicardi Goutieres Syndrome Total Market Share (%) Distribution in 2017

4.2. Aicardi Goutieres Syndrome Total Market Share (%) Distribution in 2030

5. Aicardi Goutieres Syndrome : Disease Background and Overview

6. Patient Journey

7. Aicardi Goutieres Syndrome Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

9. Unmet Needs

10. Key Endpoints of Aicardi Goutieres Syndrome Treatment

11. Marketed Products

12. Emerging Therapies

13. Aicardi Goutieres Syndrome : Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of Aicardi Goutieres Syndrome

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

 

DelveInsght’s Competitive Intelligence Service includes a multidimensional coverage, helping to keep track of competitors and gain traction in the dynamic market by overcoming the challenges and expediting business growth through a strategic and tactical approach.

 

About Delveinsight: 

DelveInsight Business Research is a leading Market Research, and Business Consultant focused purely on Healthcare. It helps pharma companies by providing them with end-to-end services to solve their business problems.

Get hold of all the Pharma and healthcare market research reports on our market research subscription-based platform PharmDelve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/report-store/aicardi-goutieres-syndrome-market